Brief: Deciphera Pharmaceuticals Says Qtrly Loss Per Share $0.80

Deciphera Pharmaceuticals

04/05/2022 13:54

May 4 (Reuters) - Deciphera Pharmaceuticals Inc  DCPH.O :
    * QTRLY LOSS PER SHARE $0.80
    * DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER
2022
FINANCIAL RESULTS
    * Q1 REVENUE $29.2 MILLION
    * DECIPHERA PHARMA - AS OF MARCH 31, 2022, CASH, CASH
EQUIVALENTS,
&MARKETABLE SECURITIES WERE $275.4 MILLION, COMPARED TO $327.6
MILLION AS OF DEC 31, 2021
    * DECIPHERA-SEES CURRENT CASH, CASH EQUIVALENTS, &
MARKETABLE
SECURITIES, ANTICIPATED PRODUCT, ROYALTY, & SUPPLY REVENUE TO
FUND OPERATING & CAPEX INTO 2025
    * Q1 EARNINGS PER SHARE VIEW $-0.90, REVENUE VIEW $26.4
MILLION --
REFINITIV IBES DATA

Further company coverage:  DCPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))